- Home
- SKIN vs PROF Comparison
SKIN vs PROF Comparison
Compare SKIN & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKIN
- PROF
- Stock Information
- Founded
- SKIN 1997
- PROF N/A
- Country
- SKIN United States
- PROF Canada
- Employees
- SKIN N/A
- PROF N/A
- Industry
- SKIN Package Goods/Cosmetics
- PROF Medical/Dental Instruments
- Sector
- SKIN Consumer Discretionary
- PROF Health Care
- Exchange
- SKIN Nasdaq
- PROF Nasdaq
- Market Cap
- SKIN 199.8M
- PROF 227.3M
- IPO Year
- SKIN N/A
- PROF N/A
- Fundamental
- Price
- SKIN $1.52
- PROF $7.30
- Analyst Decision
- SKIN Hold
- PROF Strong Buy
- Analyst Count
- SKIN 5
- PROF 2
- Target Price
- SKIN $2.55
- PROF $11.40
- AVG Volume (30 Days)
- SKIN 624.5K
- PROF 73.4K
- Earning Date
- SKIN 02-27-2025
- PROF 03-06-2025
- Dividend Yield
- SKIN N/A
- PROF N/A
- EPS Growth
- SKIN N/A
- PROF N/A
- EPS
- SKIN N/A
- PROF N/A
- Revenue
- SKIN $347,620,000.00
- PROF $8,984,000.00
- Revenue This Year
- SKIN N/A
- PROF $57.62
- Revenue Next Year
- SKIN $1.79
- PROF $160.54
- P/E Ratio
- SKIN N/A
- PROF N/A
- Revenue Growth
- SKIN N/A
- PROF 39.35
- 52 Week Low
- SKIN $0.91
- PROF $6.78
- 52 Week High
- SKIN $5.17
- PROF $11.42
- Technical
- Relative Strength Index (RSI)
- SKIN 45.99
- PROF 44.38
- Support Level
- SKIN $1.56
- PROF $7.51
- Resistance Level
- SKIN $1.92
- PROF $7.88
- Average True Range (ATR)
- SKIN 0.13
- PROF 0.36
- MACD
- SKIN -0.01
- PROF 0.02
- Stochastic Oscillator
- SKIN 23.30
- PROF 42.98
About SKIN The Beauty Health Company
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets, and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.